MedTrace Logo

Preoperative Chemoradiation Versus Short Term Radiation Alone With Delayed Surgery for Stage II and III Resectable Rectal Cancer

NCT00597311 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2008-01-18

No results posted yet for this study

Summary

Trial compares two preoperative stage II and III rectal cancer treatment strategies: short term radiotherapy 5x5 Gy and delayed surgery after 6 weeks versus conventional chemoradiotherapy 50 Gy + 5Fu/Lv and surgery also after 6 weeks.

Conditions

  • Primary Rectal Cancer

Interventions

RADIATION

radiotherapy

1. Short term radiotherapy 5x5 Gy during 5 days 2. Chemoradiotherapy 50 Gy + 5Fu/Lv

Sponsors & Collaborators

  • Kaunas University of Medicine

    lead OTHER

Principal Investigators

  • Dainius Pavalkis, professor · Kaunas Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Lithuania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00597311 on ClinicalTrials.gov